Earmarked funding – call 2023.1

€8 million for biotech, medtech & digital health

Earmarked funding for innovations in biotech, medtech and digital health technology.

Disruptive innovations happen when different technology sectors join forces.

In 2022 MEDVIA – supported by VLAIO – will provide €8 million in earmarked, non-dilutive funding for innovations in biotechnology, medical technology, and digital health technology.

The projects – combining at least two of the above sectors – should develop disruptive solutions for a clearly defined unmet need in healthcare or pool their research specialties to gain knowledge that will lead to such solutions. The results need to lead to a quantifiable increase in investment and employment in Flanders.

Call for projects 2023.1

Watch the information webinar

How to apply?

Your project should connect with one of our four overarching themes: Value-based healthcare, personalized medicine, digital medicine or disruptive health solutions.

Download the PDF document for more details. Additional documentation is available below.

The deadline for abstract submission is 23 February at noon. Click here for additional dates associated with the call.

Call 2023.1 information document


Send download link to:

Templates full proposal

Grant options.

We opened four different VLAIO grant schemes:

  • Feasibility study
  • Research Innovation Grant
  • Development Innovation Grant
  • ICON

We help you succeed.

MEDVIA assists participants with the preparation of their proposal. Of course, all participants bear full and final responsibility for writing and preparing a proposal that meets the criteria set by VLAIO for the respective grant schemes.

Interested in our future calls?